Frame 1000003625
Frame 1000003626

AI-guided life sciences intelligence for better BD&L decisions

AI-Guided Search Workflow From natural language query to structured BD&L output
ai flowchart
ai flowchart tablet
ai flowchart mobile

See the platform in action

Watch a short walkthrough of Biotechgate's AI-guided search workflows.

Watch video

Identify licensing opportunities, qualified partners, investment prospects and competitive signals with less manual research. Search structured, sourced life sciences data, human-curated research content and AI-guided workflows. All in one intelligence platform.

Some of our clients

Our Platform

Two AI-guided workflows.
One life sciences intelligence platform.

Biotechgate combines deep life sciences data with AI-guided search and research workflows. Whether you're identifying licensing opportunities or conducting due diligence, you get to the insight that matters without spending hours piecing information together.

BD&L Intelligence

Search in plain language across companies, assets, licensing opportunities, deals, trials, financing rounds, management contacts and partnering interests. Just describe what you're looking for and Biotechgate translates it into precise, structured results. No complex query language. No dead ends.

Explore BD&L Intelligence

AI Research Workspace

Ask questions across curated analyst reports and financial models to support due diligence, valuation, pipeline assessment and market research. Get sourced insights from trusted research content, so your team can spend less time reviewing documents and more time deciding what matters.

Explore AI Research Workspace
Our Coverage

Structured data and
research intelligence behind every AI-guided workflow.

Biotechgate's intelligence layer connects curated company, asset, clinical, financial, deal and contact data - giving your team the structured foundation needed for faster search, analysis and business development decisions.

70K+

Company Profiles

Global life sciences companies with structured business and pipeline data.

385K+

Management Contacts

Executive and functional contacts for outreach, qualification and partnering.

42K+

Licensing-ready Assets

Assets and technologies with development phase, indication and licensing status.

1M+

Clinical Trials

Trial activity to support pipeline, competitor and market analysis.

250K+

Reports & Forecast Models

Curated analyst reports and financial models for research, valuation and due diligence.

48K+

License Agreements

Deal terms, territories, payment structures and original contract references.

Curated, continuously updated life science intelligence - combining structured data, expert review and source-based research content.

baner overview

Aug 31 – Sep 4, 2026

Free registration

BIOTECHGATE DIGITAL PARTNERING

Virtual business development & licensing event

Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.

What our clients say

“Since I started to use Biotechgate my prospective activities have become far less time-consuming and the collected information much more up-to-date which is most satisfactory.”

Linda Slipko

Business Development Manager at GreenLight Clinical

We have used Biotechgate for a year now and we have been very satisfied with the system so far. It has provided us with an enormous amount of business intelligence of our marketplace.

Chris Huiskamp

Managing Partner at Sourcia

Liftstream was compelled to subscribe to Biotechgate as it is really the only international database of the life sciences sector which is frequently updated by those who are listed on it. This ensures that you can access and retrieve information based on geography, therapy, modality, management or any other category of information which is important to your search.

Karl Simpson

CEO at Liftstream

Upcoming Conferences

 

06October2026
08October2026

CPHI Milan 2026

Milan, Italy
CPHI Milan 2026 is the world’s largest pharmaceutical trade fair, that will bringing the global pharma community together at Fiera Milano from October 06–08, 2026. In this 35th year of innovation, the CPHI Worldwide Milan 2026 will have over 62,000 visitors, and 2,400 exhibitors, from 166+ countries.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
07October2026
08October2026

26th Annual Biotech in Europe Forum

Basel, Switzerland
Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
07October2026
09October2026

BioJapan

Yokohama, Japan
BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering. This year marks the 40th Anniversary since the first edition held in 1986, making BioJapan the world’s longest-running biotech exhibition. Along with its two co-located shows —Regenerative Medicine JAPAN, which accelerates R&D and commercialization in regenerative medicine, and healthTECH JAPAN, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences — BioJapan continues to drive innovation and collaboration in the industry.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
20October2026
20October2026

AusBiotech Invest

Queensland, Australia
AusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences. More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more

See how Biotechgate can enhance
your business development